| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $209.4M | +11.9% |
| Cost of Revenue | $41.1M | +16.8% |
| Gross Profit | $168.3M | +10.7% |
| R&D Expense | $20.6M | +33.3% |
| SG&A Expense | $55.7M | +18.5% |
| Operating Income | -$55.7M | -8.3% |
| Interest Expense | $5.3M | +1.7% |
| Income Tax | $0 | — |
| Net Income | -$55.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.3M | -12.6% |
| Short-term Investments | $64.3M | -41.6% |
| Accounts Receivable | $40.8M | +7.2% |
| Inventory | $39.3M | +34.2% |
| Current Assets | $161.4M | -18.6% |
| Total Assets | $217.1M | -13.8% |
| Current Liabilities | $34.9M | -22.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.2M | -7.5% |
| Capital Expenditures | $11.6M | +1.2% |
| Investing Cash Flow | $35.4M | +143.5% |
| Financing Cash Flow | $160K | -99.9% |
| Free Cash Flow | -$48.8M | -5.9% |
| -12.6% |
| EPS (Basic) | -$0.90 | -11.1% |
| EPS (Diluted) | -$0.90 | -11.1% |
| Long-term Debt |
| $53.3M |
| +0.6% |
| Total Liabilities | $104.2M | -8.6% |
| Stockholders' Equity | $112.9M | -18.2% |